Zinzino AB Series B Total Liabilities
Zinzino AB Series B total liabilities. Based on the latest financial reports, Zinzino AB Series B (ZZ-B) has total liabilities worth Skr1.14 Billion SEK (≈ $122.71 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See defensive interval ratio of Zinzino AB Series B to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Zinzino AB Series B (2009–2025)
Total liabilities of Zinzino AB Series B from 2009 to 2025. This chart illustrates how Zinzino AB Series B's total liabilities have evolved over time, based on quarterly financial data.
Zinzino AB Series B Competitors by Total Liabilities
The table below lists competitors of Zinzino AB Series B ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Guangzhou Huayan Precision Machinery Co.Ltd.
SHE:301138
|
China | CN¥608.81 Million |
|
Mudanjiang Hengfeng Paper Co Ltd
SHG:600356
|
China | CN¥1.33 Billion |
|
Liaoning Fu-An
SHG:603315
|
China | CN¥1.49 Billion |
|
Dalmia Bharat Sugar and Industries Limited
NSE:DALMIASUG
|
India | Rs22.86 Billion |
|
Jiangsu Huachen Transformer
SHG:603097
|
China | CN¥2.14 Billion |
|
PureTech Health PLC
NASDAQ:PRTC
|
USA | $229.03 Million |
|
Shanghai Titan Scientific Co. Ltd. A
SHG:688133
|
China | CN¥2.07 Billion |
|
InBody Co.Ltd
KQ:041830
|
Korea | ₩36.31 Billion |
Liability Composition Analysis (2009–2025)
This chart breaks down Zinzino AB Series B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Zinzino AB Series B.
Liquidity & Leverage Metrics
Zinzino AB Series B Total Liabilities Ratios Explained
Zinzino AB Series B total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.53 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.98 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.50 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zinzino AB Series B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zinzino AB Series B (2009–2025)
The table below shows the annual total liabilities of Zinzino AB Series B from 2009 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr1.05 Billion ≈ $112.49 Million |
+27.64% |
| 2024-12-31 | Skr818.94 Million ≈ $88.13 Million |
+41.60% |
| 2023-12-31 | Skr578.34 Million ≈ $62.24 Million |
+17.82% |
| 2022-12-31 | Skr490.88 Million ≈ $52.83 Million |
+8.25% |
| 2021-12-31 | Skr453.49 Million ≈ $48.80 Million |
+16.66% |
| 2020-12-31 | Skr388.73 Million ≈ $41.83 Million |
+45.94% |
| 2019-12-31 | Skr266.36 Million ≈ $28.66 Million |
+28.46% |
| 2018-12-31 | Skr207.34 Million ≈ $22.31 Million |
+106.26% |
| 2017-12-31 | Skr100.52 Million ≈ $10.82 Million |
+14.66% |
| 2016-12-31 | Skr87.67 Million ≈ $9.43 Million |
+24.33% |
| 2015-12-31 | Skr70.52 Million ≈ $7.59 Million |
-11.12% |
| 2014-12-31 | Skr79.34 Million ≈ $8.54 Million |
+133.86% |
| 2013-12-31 | Skr33.93 Million ≈ $3.65 Million |
-1.85% |
| 2012-12-31 | Skr34.57 Million ≈ $3.72 Million |
+128.60% |
| 2011-12-31 | Skr15.12 Million ≈ $1.63 Million |
+15.00% |
| 2010-12-31 | Skr13.15 Million ≈ $1.42 Million |
+46.18% |
| 2009-12-31 | Skr8.99 Million ≈ $968.01K |
-- |
About Zinzino AB Series B
Zinzino AB (publ), a direct sales company, provides dietary supplements and skincare products in Sweden and internationally. The company operates through two segments, Zinzino and Faun. It offers skincare products including cleansers, face creams, serums, and masks. The company provides coffee, coffee machines, accessories, and cups; immune, omega, and restored supplements; weight management prod… Read more